Glenmark to Conduct Phase 1 Trials of Its Molecule on Cancer Patients
Glenmark Pharma said it had received approval from the Drug Controller General of India (DCGI) to conduct phase 1 clinical trials of its molecule, GRC...
Tag : Drug Controller General of India (DCGI)
Zydus Gets DCGI Nod For Drug to Treat Anaemia Linked With Kidney Disease
Zydus Lifesciences announced that it had received approval from the Drug Controller General of India (DCGI) for Oxemia, an oral treatment for anaemia linked with...
ZyCoV-D to Get Permission For Emergency Use This Week
Zydus Cadila‘s Covid-19 vaccine ZyCoV-D is getting a nod for emergency use in India by this week. Union Health Minister Mansukh Mandaviya in the Rajya...
DCGI Approves Use of Sputnik V Vaccine
The Drug Controller General of India (DCGI) has approved the restricted emergency use of the Sputnik V vaccine late Monday night. With this, India now...
Dr Reddy’s Launches Remdesivir for COVID-19 Treatment
Dr Reddy’s Laboratories Limited announced the launch of Remdesivir on Wednesday, under the brand name of ‘Redyx’ for the treatment of COVID-19 patients in India. According...
Mylan to Manufacture DESREMTM in Bengaluru
The global pharmaceutical company has revealed that DESREMTM will be available to patients at 4,800 per 100 mg vial.On Monday, Mylan announced the commercial launch of its...
Glenmark Pharma Shares Jump Nearly 9% on DCGI
On Thursday, Glenmark Pharmaceuticals’ gained nearly 9 per cent after the company said it has received approval from DCGI to conduct clinical trials of tablets...